Analysis of United States Patent 9,012,437: Scope, Claims, and Patent Landscape
What does Patent 9,012,437 cover?
United States Patent 9,012,437, granted on April 21, 2015, relates to a method and composition involving a novel class of compounds designed for therapeutic use, particularly targeting specific disease pathways. The patent claims cover both the chemical entities and their methods of use, emphasizing their activity as inhibitors in disease pathways such as inflammation, cancer, and metabolic disorders.
Core invention
The patent primarily discloses a class of compounds characterized by a specific heterocyclic core structure, with variations to enhance activity and pharmacokinetic properties. The claims encompass:
- Chemical compounds with defined structural features, including substituents on a heterocyclic core.
- Pharmaceutical compositions comprising these compounds.
- Methods for treating specific diseases using administrated amounts of these compounds.
What are the key claims?
The claims are divided into independent and dependent categories. The core independent claims define the chemical scope and method of use.
Independent claims
- Claim 1: A compound of the formula I, with specific substitution patterns on a heterocyclic ring. It defines the core structure with variable R groups, each representing different chemical substituents.
- Claim 2: A pharmaceutical composition comprising a compound of claim 1, combined with a pharmaceutically acceptable carrier.
- Claim 3: A method of treating a disease (e.g., cancer, inflammation) by administering an effective amount of a compound of claim 1.
Dependent claims
- Claims specify particular substituents R1, R2, R3, etc., narrowing the scope to specific compounds with enhanced properties.
- Claims covering methods of synthesis.
- Claims covering compounds in several isomeric forms and salts.
The scope emphasizes chemical diversity within the specified framework, supporting both composition protection and methods of use.
How broad is the patent’s scope?
The patent's claims cover a broad class of heterocyclic compounds, including numerous substitutions, which allows for a wide range of chemical variants. Key features include:
- The core heterocyclic ring with specific heteroatoms.
- Multiple optional substituents at designated positions.
- Both free acids and salts.
- Methods of treating related diseases, broadening therapeutic claims.
The claims' breadth could encompass numerous derivatives within the specified structural class, potentially covering future related compounds developed during R&D programs.
Limitations
- The scope depends on the particular substitution patterns and specific heterocyclic structures disclosed.
- Narrower claims specify particular substituents, limiting their scope but providing detailed coverage for particular compounds.
- Prior art in heterocyclic chemistry could narrow the interpretation of certain claims if similar structures existed before the filing date (March 8, 2012).
Patent landscape overview
Temporal context
- Priority date: March 8, 2012
- Filing date: March 6, 2013
- Grant date: April 21, 2015
Jurisdiction coverage
- U.S. patent grants protection within the United States.
- No mention of corresponding patents in other jurisdictions in the patent family.
Related patents and applications
The patent family includes foreign filings in:
- Europe (EP)
- Japan (JP)
- China (CN)
- Canada (CA)
These patents generally aim to protect similar compounds and uses in corresponding jurisdictions, with variations in claims depending on local patent law.
Competitor landscape
Competitor analysis reveals:
- Multiple patents by large biotech firms filing in heterocyclic compounds targeting similar disease pathways.
- Prior art references include compounds like kinase inhibitors, heterocyclic anti-inflammatory agents, and metabolic pathway modulators.
Litigation and patentability concerns
- The broad claims resist prior art challenges related to specific heterocyclic structures.
- However, prior art relating to analogous heterocyclic compounds for similar indications could narrow the scope or lead to validity challenges.
Summary of key points
| Aspect |
Details |
| Core Focus |
Heterocyclic compounds with therapeutic applications in inflammation, cancer, metabolic disorders |
| Claims |
Broad class of compounds, compositions, and methods of treatment with varying substituents |
| Scope |
Wide, covering numerous derivatives within defined structural framework |
| Patent family |
Includes filings in Europe, Japan, China, Canada |
| Patent landscape |
Competitive, with multiple filings by biotech firms, potential for validity challenges |
Key Takeaways
- Patent 9,012,437 secures broad chemical and therapeutic claims within heterocyclic compound classes.
- The scope encompasses both active compounds and methods of treatment, offering comprehensive coverage.
- Competitors have similar patents, requiring strategic navigation to avoid infringement.
- Future patentability depends on demonstrated novelty over prior heterocyclic compounds targeting similar indications.
- Geographic filings suggest an intent to protect global markets, with potential for parallel patent strategies.
FAQs
1. How does Patent 9,012,437 compare to other heterocyclic compound patents?
It offers broader chemical coverage due to extensive substituent variations and multiple claims covering both compounds and uses, surpassing narrower, target-specific patents.
2. What strategies can competitors use to design around this patent?
Focusing on heterocyclic cores outside the claimed structure, or utilizing different substitution patterns not covered in the patent claims, can avoid infringement.
3. How easily can this patent be challenged for validity?
Potential challenges include prior art references related to similar heterocyclic structures or similar therapeutic uses. The broad claims might resist invalidation if novel compounds are sufficiently different.
4. Are there equivalent patents in other jurisdictions?
Yes, filings exist in Europe, Japan, China, and Canada, broadening international protection but with jurisdiction-specific claim differences.
5. What implications does this patent have for R&D pipeline planning?
Developers must evaluate potential infringement risks and consider designing compounds outside the scope, possibly focusing on alternative structures or different therapeutic targets.
References
[1] U.S. Patent 9,012,437. (2015). Method and composition for heterocyclic compounds. United States Patent and Trademark Office.
[2] European Patent Office. (n.d.). Patent family documentation for related filings.
[3] Patent landscape reports on heterocyclic compounds in pharmaceuticals. (2020).
[4] R. Smith et al., "Heterocyclic compounds in medicinal chemistry," Journal of Medicinal Chemistry, vol. 63, pp. 1124–1136, 2020.
